NF-κB signaling as a driver of ageing

International Review of Cell and Molecular Biology

Volumn 326, Issue , 2016, Pages 133-174

  Osorio, F G ^a   Soria Valles, C ^a   Santiago Fernandez O ^a   Freije, J M P ^a   Lopez Otin C ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

ageing; inflammation; NF B; progeria

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FAT; GLYCINE; I KAPPA B BETA; I KAPPA B KINASE; I KAPPA B KINASE COMPLEX; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; KLOTHO PROTEIN; LAMIN A; MAMMALIAN TARGET OF RAPAMYCIN; METALLOPROTEINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEAR FACTOR KAPPA B 1; NUCLEIC ACID BINDING PROTEIN; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 6; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WNT PROTEIN; ZMPSTE24 PROTEASE;

ADAPTIVE IMMUNITY; AGING; AMINO ACID SUBSTITUTION; APOPTOSIS; BIOLOGICAL FUNCTIONS; CANONICAL ANALYSIS; CELL AGING; CELL COMMUNICATION; CELL DAMAGE; CELL SURFACE; CHRONIC INFLAMMATION; CYTOLOGY; CYTOPLASM; CYTOSOL; DNA DAMAGE RESPONSE; DNA REPAIR; ENZYME INHIBITION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOSENESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; LONGEVITY; MALIGNANT TRANSFORMATION; MARKOV CHAIN; MECHANOTRANSDUCTION; MEDIATOR; METABOLISM; MICROBIAL COMMUNITY; MICROFLORA; MUSCLE ATROPHY; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PHENOTYPE; PROGERIA; REJUVENATION; SIGNAL TRANSDUCTION; STEM CELL; SYSTEMS BIOLOGY; TELOMERE; WERNER SYNDROME; WNT SIGNALING PATHWAY; ANIMAL;

AGING; ANIMALS; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84975152247     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.04.003     Document Type: Chapter

References (205)

1. Adler, A.S., Sinha, S., Kawahara, T.L., Zhang, J.Y., Segal, E., Chang, H.Y., Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 21 (2007), 3244–3257.
2. Adler, A.S., Kawahara, T.L., Segal, E., Chang, H.Y., Reversal of aging by NFkappaB blockade. Cell Cycle 7 (2008), 556–559.
3. Ak, P., Levine, A.J., p53 and NF-kappaB: different strategies for responding to stress lead to a functional antagonism. FASEB J. 24 (2010), 3643–3652.
4. Aleyasin, H., Cregan, S.P., Iyirhiaro, G., O'hare, M.J., Callaghan, S.M., Slack, R.S., Park, D.S., Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. 24 (2004), 2963–2973.
5. Arai, Y., Martin-Ruiz, C.M., Takayama, M., Abe, Y., Takebayashi, T., Koyasu, S., Suematsu, M., Hirose, N., Von Zglinicki, T., Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine 2 (2015), 1549–1558.
6. Aw, D., Palmer, D.B., The origin and implication of thymic involution. Aging Dis. 2 (2011), 437–443.
7. Aw, D., Silva, A.B., Palmer, D.B., Immunosenescence: emerging challenges for an ageing population. Immunology 120 (2007), 435–446.
8. Badr, C.E., Tannous, B.A., Bioluminescence imaging: progress and applications. Trends Biotechnol. 29 (2011), 624–633.
9. Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R.H., Schoonjans, K., Schreiber, V., Sauve, A.A., Menissier-De Murcia, J., Auwerx, J., PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13 (2011), 461–468.
10. Baker, D.J., Wijshake, T., Tchkonia, T., Lebrasseur, N.K., Childs, B.G., Van De Sluis, B., Kirkland, J.L., Van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
11. Bapat, S.P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C., Liang, Y., Leblanc, M., Liddle, C., Atkins, A.R., Yu, R.T., Downes, M., Evans, R.M., Zheng, Y., Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528 (2015), 137–141.
12. Basak, S., Shih, V.F., Hoffmann, A., Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system. Mol. Cell Biol. 28 (2008), 3139–3150.
13. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., De Cabo, R., Sinclair, D.A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006), 337–342.
14. Bektas, A., Zhang, Y., Lehmann, E., Wood, W.H. 3rd, Becker, K.G., Madara, K., Ferrucci, L., Sen, R., Age-associated changes in basal NF-kappaB function in human CD4+ T lymphocytes via dysregulation of PI3 kinase. Aging (Albany NY) 6 (2014), 957–974.
15. Bernal, G.M., Wahlstrom, J.S., Crawley, C.D., Cahill, K.E., Pytel, P., Liang, H., Kang, S., Weichselbaum, R.R., Yamini, B., Loss of Nfkb1 leads to early onset aging. Aging (Albany NY) 6 (2014), 931–943.
16. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkila, J., Monti, D., Satokari, R., Franceschi, C., Brigidi, P., De Vos, W., Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE, 5, 2010, e10667.
17. Biton, S., Ashkenazi, A., NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 145 (2011), 92–103.
18. Boehm, J.S., Zhao, J.J., Yao, J., Kim, S.Y., Firestein, R., Dunn, I.F., Sjostrom, S.K., Garraway, L.A., Weremowicz, S., Richardson, A.L., Greulich, H., Stewart, C.J., Mulvey, L.A., Shen, R.R., Ambrogio, L., Hirozane-Kishikawa, T., Hill, D.E., Vidal, M., Meyerson, M., Grenier, J.K., Hinkle, G., Root, D.E., Roberts, T.M., Lander, E.S., Polyak, K., Hahn, W.C., Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129 (2007), 1065–1079.
19. Botelho, M., Cavadas, C., Neuropeptide Y: an anti-aging player?. Trends Neurosci. 38 (2015), 701–711.
20. Bredel, M., Scholtens, D.M., Yadav, A.K., Alvarez, A.A., Renfrow, J.J., Chandler, J.P., Yu, I.L., Carro, M.S., Dai, F., Tagge, M.J., Ferrarese, R., Bredel, C., Phillips, H.S., Lukac, P.J., Robe, P.A., Weyerbrock, A., Vogel, H., Dubner, S., Mobley, B., He, X., Scheck, A.C., Sikic, B.I., Aldape, K.D., Chakravarti, A., Harsh, G.R.T., NFKBIA deletion in glioblastomas. N. Engl. J. Med. 364 (2011), 627–637.
21. Bredemeyer, A.L., Helmink, B.A., Innes, C.L., Calderon, B., Mcginnis, L.M., Mahowald, G.K., Gapud, E.J., Walker, L.M., Collins, J.B., Weaver, B.K., Mandik-Nayak, L., Schreiber, R.D., Allen, P.M., May, M.J., Paules, R.S., Bassing, C.H., Sleckman, B.P., DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 456 (2008), 819–823.
22. Bu, D.X., Johansson, M.E., Ren, J., Xu, D.W., Johnson, F.B., Edfeldt, K., Yan, Z.Q., Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 2604–2610.
23. Burkle, A., DNA repair and PARP in aging. Free Radic. Res. 40 (2006), 1295–1302.
24. Burtner, C.R., Kennedy, B.K., Progeria syndromes and ageing: what is the connection?. Nat. Rev. Mol. Cell Biol. 11 (2010), 567–578.
25. Cabanillas, R., Cadinanos, J., Villameytide, J.A., Perez, M., Longo, J., Richard, J.M., Alvarez, R., Duran, N.S., Illan, R., Gonzalez, D.J., Lopez-Otin, C., Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am. J. Med. Genet. A 155A (2011), 2617–2625.
26. Cai, D., Liu, T., Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging (Albany NY) 4 (2012), 98–115.
27. Cai, D., Frantz, J.D., Tawa, N.E. Jr., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J., Shoelson, S.E., IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119 (2004), 285–298.
28. Calabrese, V., Cornelius, C., Cuzzocrea, S., Iavicoli, I., Rizzarelli, E., Calabrese, E.J., Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol. Aspects Med. 32 (2011), 279–304.
29. Campisi, J., Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005), 513–522.
30. Carlsen, H., Moskaug, J.O., Fromm, S.H., Blomhoff, R., In vivo imaging of NF-kappa B activity. J. Immunol. 168 (2002), 1441–1446.
31. Carrero, D., Soria-Valles, C., Lopez-Otin, C., Progeroid syndromes as models of aging: lessons from mice and reprogrammed cells. Dis. Model Mech., 2016 in press.
32. Cau, P., Navarro, C., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, E., Perrin, S., De Sandre-Giovannoli, A., Levy, N., Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin. Cell Dev. Biol. 29 (2014), 125–147.
33. Cevenini, E., Monti, D., Franceschi, C., Inflamm-ageing. Curr. Opin. Clin. Nutr. Metab. Care 16 (2013), 14–20.
34. Chang, J., Wang, Z., Tang, E., Fan, Z., Mccauley, L., Franceschi, R., Guan, K., Krebsbach, P.H., Wang, C.Y., Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med. 15 (2009), 682–689.
35. Chen, Q., Liu, K., Robinson, A.R., Clauson, C.L., Blair, H.C., Robbins, P.D., Niedernhofer, L.J., Ouyang, H., DNA damage drives accelerated bone aging via an NF-kappaB-dependent mechanism. J. Bone Miner. Res. 28 (2013), 1214–1228.
36. Chen, H., Zheng, X., Zheng, Y., Age-associated loss of lamin-B leads to systemic inflammation and gut hyperplasia. Cell 159 (2014), 829–843.
37. Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J.E., Premsrirut, P., Luo, W., Chicas, A., Lee, C.S., Kogan, S.C., Lowe, S.W., Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev. 25 (2011), 2125–2136.
38. Chirumbolo, S., Possible role of NF-kappaB in hormesis during ageing. Biogerontology 13 (2012), 637–646.
39. Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
40. Courtois, G., Gilmore, T.D., Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25 (2006), 6831–6843.
41. Dan, H.C., Cooper, M.J., Cogswell, P.C., Duncan, J.A., Ting, J.P., Baldwin, A.S., Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 22 (2008), 1490–1500.
42. De La Rosa, J., Freije, J.M., Cabanillas, R., Osorio, F.G., Fraga, M.F., Fernandez-Garcia, M.S., Rad, R., Fanjul, V., Ugalde, A.P., Liang, Q., Prosser, H.M., Bradley, A., Cadinanos, J., Lopez-Otin, C., Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion. Nat. Commun., 4, 2013, 2268.
43. De Vos, D., Frederiks, F., Terweij, M., Van Welsem, T., Verzijlbergen, K.F., Iachina, E., De Graaf, E.L., Altelaar, A.F., Oudgenoeg, G., Heck, A.J., Krijgsveld, J., Bakker, B.M., Van Leeuwen, F., Progressive methylation of ageing histones by Dot1 functions as a timer. EMBO Rep. 12 (2011), 956–962.
44. Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., Laberge, R.M., Vijg, J., Van Steeg, H., Dolle, M.E., Hoeijmakers, J.H., De Bruin, A., Hara, E., Campisi, J., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31 (2014), 722–733.
45. Djavaheri-Mergny, M., Amelotti, M., Mathieu, J., Besancon, F., Bauvy, C., Souquere, S., Pierron, G., Codogno, P., NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J. Biol. Chem. 281 (2006), 30373–30382.
46. Doles, J., Storer, M., Cozzuto, L., Roma, G., Keyes, W.M., Age-associated inflammation inhibits epidermal stem cell function. Genes Dev. 26 (2012), 2144–2153.
47. Eisenberg, T., Knauer, H., Schauer, A., Buttner, S., Ruckenstuhl, C., Carmona-Gutierrez, D., Ring, J., Schroeder, S., Magnes, C., Antonacci, L., Fussi, H., Deszcz, L., Hartl, R., Schraml, E., Criollo, A., Megalou, E., Weiskopf, D., Laun, P., Heeren, G., Breitenbach, M., Grubeck-Loebenstein, B., Herker, E., Fahrenkrog, B., Frohlich, K.U., Sinner, F., Tavernarakis, N., Minois, N., Kroemer, G., Madeo, F., Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol. 11 (2009), 1305–1314.
48. Elsharkawy, A.M., Oakley, F., Lin, F., Packham, G., Mann, D.A., Mann, J., The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J. Hepatol. 53 (2010), 519–527.
49. Encode. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (2012), 57–74.
50. Erener, S., Petrilli, V., Kassner, I., Minotti, R., Castillo, R., Santoro, R., Hassa, P.O., Tschopp, J., Hottiger, M.O., Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-kappaB target genes. Mol. Cell. 46 (2012), 200–211.
51. Ermolaeva, M.A., Schumacher, B., Systemic DNA damage responses: organismal adaptations to genome instability. Trends Genet. 30 (2014), 95–102.
52. Ermolaeva, M.A., Segref, A., Dakhovnik, A., Ou, H.L., Schneider, J.I., Utermohlen, O., Hoppe, T., Schumacher, B., DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance. Nature 501 (2013), 416–420.
53. Espada, J., Varela, I., Flores, I., Ugalde, A.P., Cadinanos, J., Pendas, A.M., Stewart, C.L., Tryggvason, K., Blasco, M.A., Freije, J.M., Lopez-Otin, C., Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J. Cell Biol. 181 (2008), 27–35.
54. Esser, N., Paquot, N., Scheen, A.J., Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Expert Opin. Investig. Drugs 24 (2015), 283–307.
55. Fanjul-Fernandez, M., Folgueras, A.R., Cabrera, S., Lopez-Otin, C., Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim. Biophys. Acta 1803 (2010), 3–19.
56. Fernandez, P., Scaffidi, P., Markert, E., Lee, J.H., Rane, S., Misteli, T., Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4. Cell Rep. 9 (2014), 248–260.
57. Finch, C.E., Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc. Natl. Acad. Sci. USA 107:Suppl. 1 (2010), 1718–1724.
58. Fontana, L., Partridge, L., Longo, V.D., Extending healthy life span—from yeast to humans. Science 328 (2010), 321–326.
59. Freije, J.M., Lopez-Otin, C., Reprogramming aging and progeria. Curr. Opin. Cell Biol. 24 (2012), 757–764.
60. Freund, A., Orjalo, A.V., Desprez, P.Y., Campisi, J., Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16 (2010), 238–246.
61. Fujioka, S., Schmidt, C., Sclabas, G.M., Li, Z., Pelicano, H., Peng, B., Yao, A., Niu, J., Zhang, W., Evans, D.B., Abbruzzese, J.L., Huang, P., Chiao, P.J., Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J. Biol. Chem. 279 (2004), 27549–27559.
62. Gasser, S., Orsulic, S., Brown, E.J., Raulet, D.H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005), 1186–1190.
63. Ghosh, A., Roy, A., Liu, X., Kordower, J.H., Mufson, E.J., Hartley, D.M., Ghosh, S., Mosley, R.L., Gendelman, H.E., Pahan, K., Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 104 (2007), 18754–18759.
64. Ghosh, A., Saginc, G., Leow, S.C., Khattar, E., Shin, E.M., Yan, T.D., Wong, M., Zhang, Z., Li, G., Sung, W.K., Zhou, J., Chng, W.J., Li, S., Liu, E., Tergaonkar, V., Telomerase directly regulates NF-kappaB-dependent transcription. Nat. Cell Biol. 14 (2012), 1270–1281.
65. Gilmore, T.D., Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18 (1999), 6925–6937.
66. Gilmore, T.D., Kalaitzidis, D., Liang, M.C., Starczynowski, D.T., The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 23 (2004), 2275–2286.
67. Gordon, L.B., Rothman, F.G., Lopez-Otin, C., Misteli, T., Progeria: a paradigm for translational medicine. Cell 156 (2014), 400–407.
68. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., Edkins, S., O'meara, S., Vastrik, I., Schmidt, E.E., Avis, T., Barthorpe, S., Bhamra, G., Buck, G., Choudhury, B., Clements, J., Cole, J., Dicks, E., Forbes, S., Gray, K., Halliday, K., Harrison, R., Hills, K., Hinton, J., Jenkinson, A., Jones, D., Menzies, A., Mironenko, T., Perry, J., Raine, K., Richardson, D., Shepherd, R., Small, A., Tofts, C., Varian, J., Webb, T., West, S., Widaa, S., Yates, A., Cahill, D.P., Louis, D.N., Goldstraw, P., Nicholson, A.G., Brasseur, F., Looijenga, L., Weber, B.L., Chiew, Y.E., Defazio, A., Greaves, M.F., Green, A.R., Campbell, P., Birney, E., Easton, D.F., Chenevix-Trench, G., Tan, M.H., Khoo, S.K., Teh, B.T., Yuen, S.T., Leung, S.Y., Wooster, R., Futreal, P.A., Stratton, M.R., Patterns of somatic mutation in human cancer genomes. Nature 446 (2007), 153–158.
69. Greer, E.L., Brunet, A., FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 (2005), 7410–7425.
70. Grosjean-Raillard, J., Tailler, M., Ades, L., Perfettini, J.L., Fabre, C., Braun, T., De Botton, S., Fenaux, P., Kroemer, G., ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 28 (2009), 1099–1109.
71. Gutierrez-Fernandez, A., Soria-Valles, C., Osorio, F.G., Gutierrez-Abril, J., Garabaya, C., Aguirre, A., Fueyo, A., Fernandez-Garcia, M.S., Puente, X.S., Lopez-Otin, C., Loss of MT1-MMP causes cell senescence and nuclear defects which can be reversed by retinoic acid. EMBO J. 34 (2015), 1875–1888.
72. Hagemann, T., Lawrence, T., Mcneish, I., Charles, K.A., Kulbe, H., Thompson, R.G., Robinson, S.C., Balkwill, F.R., “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J. Exp. Med. 205 (2008), 1261–1268.
73. Hannun, Y.A., Luberto, C., Ceramide in the eukaryotic stress response. Trends Cell Biol. 10 (2000), 73–80.
74. Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S., Pahor, M., Javors, M.A., Fernandez, E., Miller, R.A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460 (2009), 392–395.
75. Hassa, P.O., Hottiger, M.O., The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol. Life Sci. 59 (2002), 1534–1553.
76. Hayden, M.S., Ghosh, S., Shared principles in NF-kappaB signaling. Cell 132 (2008), 344–362.
77. Hayden, M.S., Ghosh, S., NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26 (2012), 203–234.
78. Helenius, M., Hanninen, M., Lehtinen, S.K., Salminen, A., Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J. Mol. Cell Cardiol. 28 (1996), 487–498.
79. Helenius, M., Hanninen, M., Lehtinen, S.K., Salminen, A., Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem. J. 318:Pt. 2 (1996), 603–608.
80. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even, P.C., Cervera, P., Le Bouc, Y., IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 (2003), 182–187.
81. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., Karin, M., Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284 (1999), 316–320.
82. Huang, T.T., Wuerzberger-Davis, S.M., Wu, Z.H., Miyamoto, S., Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115 (2003), 565–576.
83. Huang, M.C., Liao, J.J., Bonasera, S., Longo, D.L., Goetzl, E.J., Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J. 22 (2008), 2142–2150.
84. Iannetti, A., Ledoux, A.C., Tudhope, S.J., Sellier, H., Zhao, B., Mowla, S., Moore, A., Hummerich, H., Gewurz, B.E., Cockell, S.J., Jat, P.S., Willmore, E., Perkins, N.D., Regulation of p53 and Rb links the alternative NF-kappaB pathway to EZH2 expression and cell senescence. PLoS Genet., 10, 2014, e1004642.
85. Irazoqui, J.E., Urbach, J.M., Ausubel, F.M., Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10 (2010), 47–58.
86. Janssens, S., Tschopp, J., Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ. 13 (2006), 773–784.
87. Jenny, N.S., French, B., Arnold, A.M., Strotmeyer, E.S., Cushman, M., Chaves, P.H., Ding, J., Fried, L.P., Kritchevsky, S.B., Rifkin, D.E., Sarnak, M.J., Newman, A.B., Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J. Gerontol. A Biol. Sci. Med. Sci. 67 (2012), 970–976.
88. Josson, S., Xu, Y., Fang, F., Dhar, S.K., St Clair, D.K., St Clair, W.H., RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Oncogene 25 (2006), 1554–1559.
89. Jurk, D., Wilson, C., Passos, J.F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., Hewitt, G., Pender, S.L., Fullard, N., Nelson, G., Mann, J., Van De Sluis, B., Mann, D.A., Von Zglinicki, T., Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun., 2, 2014, 4172.
90. Kang, C., Xu, Q., Martin, T.D., Li, M.Z., Demaria, M., Aron, L., Lu, T., Yankner, B.A., Campisi, J., Elledge, S.J., The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science, 349, 2015, aaa5612.
91. Karakasilioti, I., Kamileri, I., Chatzinikolaou, G., Kosteas, T., Vergadi, E., Robinson, A.R., Tsamardinos, I., Rozgaja, T.A., Siakouli, S., Tsatsanis, C., Niedernhofer, L.J., Garinis, G.A., DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria. Cell Metab. 18 (2013), 403–415.
92. Karin, M., Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006), 431–436.
93. Karin, M., Lin, A., NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002), 221–227.
94. Karpac, J., Younger, A., Jasper, H., Dynamic coordination of innate immune signaling and insulin signaling regulates systemic responses to localized DNA damage. Dev. Cell 20 (2011), 841–854.
95. Kawahara, T.L., Michishita, E., Adler, A.S., Damian, M., Berber, E., Lin, M., Mccord, R.A., Ongaigui, K.C., Boxer, L.D., Chang, H.Y., Chua, K.F., SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136 (2009), 62–74.
96. Kenyon, C.J., The genetics of ageing. Nature 464 (2010), 504–512.
97. Keutgens, A., Robert, I., Viatour, P., Chariot, A., Deregulated NF-kappaB activity in haematological malignancies. Biochem. Pharmacol. 72 (2006), 1069–1080.
98. Kim, M.Y., Zhang, T., Kraus, W.L., Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear signal. Genes Dev. 19 (2005), 1951–1967.
99. Kizil, C., Kyritsis, N., Brand, M., Effects of inflammation on stem cells: together they strive?. EMBO Rep. 16 (2015), 416–426.
100. Korhonen, P., Helenius, M., Salminen, A., Age-related changes in the regulation of transcription factor NF-kappa B in rat brain. Neurosci. Lett. 225 (1997), 61–64.
101. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA 98 (2001), 12072–12077.
102. Kuilman, T., Peeper, D.S., Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9 (2009), 81–94.
103. Kuo, H.P., Wang, Z., Lee, D.F., Iwasaki, M., Duque-Afonso, J., Wong, S.H., Lin, C.H., Figueroa, M.E., Su, J., Lemischka, I.R., Cleary, M.L., Epigenetic roles of MLL oncoproteins are dependent on NF-kappaB. Cancer Cell. 24 (2013), 423–437.
104. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K.P., Baum, M.G., Schiavi, S., Hu, M.C., Moe, O.W., Kuro-O, M., Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281 (2006), 6120–6123.
105. Lakhdari, O., Cultrone, A., Tap, J., Gloux, K., Bernard, F., Ehrlich, S.D., Lefevre, F., Dore, J., Blottiere, H.M., Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-kappaB modulation in the human gut. PLoS ONE, 2010, 5.
106. Lakhdari, O., Tap, J., Beguet-Crespel, F., Le Roux, K., De Wouters, T., Cultrone, A., Nepelska, M., Lefevre, F., Dore, J., Blottiere, H.M., Identification of NF-kappaB modulation capabilities within human intestinal commensal bacteria. J. Biomed. Biotechnol., 2011, 2011, 282356.
107. Lee, D.F., Kuo, H.P., Chen, C.T., Hsu, J.M., Chou, C.K., Wei, Y., Sun, H.L., Li, L.Y., Ping, B., Huang, W.C., He, X., Hung, J.Y., Lai, C.C., Ding, Q., Su, J.L., Yang, J.Y., Sahin, A.A., Hortobagyi, G.N., Tsai, F.J., Tsai, C.H., Hung, M.C., IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130 (2007), 440–455.
108. Leung, T.H., Zhang, L.F., Wang, J., Ning, S., Knox, S.J., Kim, S.K., Topical hypochlorite ameliorates NF-kappaB-mediated skin diseases in mice. J. Clin. Invest. 123 (2013), 5361–5370.
109. Li, Z.W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., Karin, M., The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189 (1999), 1839–1845.
110. Li, Q., Lu, Q., Hwang, J.Y., Buscher, D., Lee, K.F., Izpisua-Belmonte, J.C., Verma, I.M., IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13 (1999), 1322–1328.
111. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., Verma, I.M., Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284 (1999), 321–325.
112. Li, C.W., Xia, W., Huo, L., Lim, S.O., Wu, Y., Hsu, J.L., Chao, C.H., Yamaguchi, H., Yang, N.K., Ding, Q., Wang, Y., Lai, Y.J., Labaff, A.M., Wu, T.J., Lin, B.R., Yang, M.H., Hortobagyi, G.N., Hung, M.C., Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res. 72 (2012), 1290–1300.
113. Libert, S., Chao, Y., Chu, X., Pletcher, S.D., Trade-offs between longevity and pathogen resistance in Drosophila melanogaster are mediated by NFkappaB signaling. Aging Cell. 5 (2006), 533–543.
114. Lin, L., Hron, J.D., Peng, S.L., Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21 (2004), 203–213.
115. Liu, Y., Drozdov, I., Shroff, R., Beltran, L.E., Shanahan, C.M., Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112 (2013), e99–e109.
116. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The hallmarks of aging. Cell 153 (2013), 1194–1217.
117. Madrid, L.V., Mayo, M.W., Reuther, J.Y., Baldwin, A.S. Jr., Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276 (2001), 18934–18940.
118. Magness, S.T., Jijon, H., Van Houten Fisher, N., Sharpless, N.E., Brenner, D.A., Jobin, C., In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J. Immunol. 173 (2004), 1561–1570.
119. Marino, G., Ugalde, A.P., Fernandez, A.F., Osorio, F.G., Fueyo, A., Freije, J.M., Lopez-Otin, C., Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proc. Natl. Acad. Sci. USA 107 (2010), 16268–16273.
120. Martin-Ruiz, C.M., Gussekloo, J., Van Heemst, D., Von Zglinicki, T., Westendorp, R.G., Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell. 4 (2005), 287–290.
121. Mauro, C., Leow, S.C., Anso, E., Rocha, S., Thotakura, A.K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A.A., Tergaonkar, V., Chandel, N.S., Franzoso, G., NF-kappaB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat. Cell Biol. 13 (2011), 1272–1279.
122. McCool, K.W., Miyamoto, S., DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out. Immunol. Rev. 246 (2012), 311–326.
123. Michishita, E., Mccord, R.A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T.L., Barrett, J.C., Chang, H.Y., Bohr, V.A., Ried, T., Gozani, O., Chua, K.F., SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452 (2008), 492–496.
124. Mitchell, S.J., Martin-Montalvo, A., Mercken, E.M., Palacios, H.H., Ward, T.M., Abulwerdi, G., Minor, R.K., Vlasuk, G.P., Ellis, J.L., Sinclair, D.A., Dawson, J., Allison, D.B., Zhang, Y., Becker, K.G., Bernier, M., De Cabo, R., The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6 (2014), 836–843.
125. Miyamoto, S., Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res. 21 (2011), 116–130.
126. Moskalev, A., Shaposhnikov, M., Pharmacological inhibition of NF-kappaB prolongs lifespan of Drosophila melanogaster. Aging (Albany NY) 3 (2011), 391–394.
127. Mostoslavsky, R., Chua, K.F., Lombard, D.B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., Mills, K.D., Patel, P., Hsu, J.T., Hong, A.L., Ford, E., Cheng, H.L., Kennedy, C., Nunez, N., Bronson, R., Frendewey, D., Auerbach, W., Valenzuela, D., Karow, M., Hottiger, M.O., Hursting, S., Barrett, J.C., Guarente, L., Mulligan, R., Demple, B., Yancopoulos, G.D., Alt, F.W., Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124 (2006), 315–329.
128. Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., Parks, R.J., Tschopp, J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008), 103–107.
129. Nakano, H., Signaling crosstalk between NF-kappaB and JNK. Trends Immunol. 25 (2004), 402–405.
130. Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.H., Xue, X., Okumura, K., Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. 13 (2006), 730–737.
131. Natoli, G., Saccani, S., Bosisio, D., Marazzi, I., Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6 (2005), 439–445.
132. Nayagam, V.M., Wang, X., Tan, Y.C., Poulsen, A., Goh, K.C., Ng, T., Wang, H., Song, H.Y., Ni, B., Entzeroth, M., Stunkel, W., SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J. Biomol. Screen. 11 (2006), 959–967.
133. Neri, A., Chang, C.C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A.T., Chaganti, R.S., Dalla-Favera, R., B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67 (1991), 1075–1087.
134. Niedernhofer, L.J., Garinis, G.A., Raams, A., Lalai, A.S., Robinson, A.R., Appeldoorn, E., Odijk, H., Oostendorp, R., Ahmad, A., Van Leeuwen, W., Theil, A.F., Vermeulen, W., Van Der Horst, G.T., Meinecke, P., Kleijer, W.J., Vijg, J., Jaspers, N.G., Hoeijmakers, J.H., A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444 (2006), 1038–1043.
135. O'brown, Z.K., Van Nostrand, E.L., Higgins, J.P., Kim, S.K., The inflammatory transcription factors NFkappaB, STAT1 and STAT3 drive age-associated transcriptional changes in the human kidney. PLoS Genet., 11, 2015, e1005734.
136. Oeckinghaus, A., Hayden, M.S., Ghosh, S., Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12 (2011), 695–708.
137. Osorio, F.G., Obaya, A.J., Lopez-Otin, C., Freije, J.M., Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res. 18 (2009), 7–15.
138. Osorio, F.G., Navarro, C.L., Cadinanos, J., Lopez-Mejia, I.C., Quiros, P.M., Bartoli, C., Rivera, J., Tazi, J., Guzman, G., Varela, I., Depetris, D., De Carlos, F., Cobo, J., Andres, V., De Sandre-Giovannoli, A., Freije, J.M., Levy, N., Lopez-Otin, C., Splicing-directed therapy in a new mouse model of human accelerated aging. Sci. Transl. Med., 3, 2011, 106ra107.
139. Osorio, F.G., Ugalde, A.P., Marino, G., Puente, X.S., Freije, J.M., Lopez-Otin, C., Cell autonomous and systemic factors in progeria development. Biochem. Soc. Trans. 39 (2011), 1710–1714.
140. Osorio, F.G., Barcena, C., Soria-Valles, C., Ramsay, A.J., De Carlos, F., Cobo, J., Fueyo, A., Freije, J.M., Lopez-Otin, C., Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26 (2012), 2311–2324.
141. Osorio, F.G., Lopez-Otin, C., Freije, J.M., NF-kB in premature aging. Aging (Albany NY) 4 (2012), 726–727.
142. Osorio, F.G., De La Rosa, J., Freije, J.M., Luminescence-based in vivo monitoring of NF-kappaB activity through a gene delivery approach. Cell Commun. Signal., 11, 2013, 19.
143. Pahl, H.L., Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999), 6853–6866.
144. Papanikolaou, V., Athanassiou, E., Dubos, S., Dimou, I., Papathanasiou, I., Kitsiou-Tzeli, S., Kappas, C., Tsezou, A., hTERT regulation by NF-kappaB and c-myc in irradiated HER2-positive breast cancer cells. Int. J. Radiat. Biol. 87 (2011), 609–621.
145. Park, J.W., Pewzner-Jung, Y., Ceramide synthases: reexamining longevity. Handb. Exp. Pharmacol. 215 (2013), 89–107.
146. Pendas, A.M., Zhou, Z., Cadinanos, J., Freije, J.M., Wang, J., Hultenby, K., Astudillo, A., Wernerson, A., Rodriguez, F., Tryggvason, K., Lopez-Otin, C., Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet. 31 (2002), 94–99.
147. Perkins, N.D., Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8 (2007), 49–62.
148. Pflueger, D., Terry, S., Sboner, A., Habegger, L., Esgueva, R., Lin, P.C., Svensson, M.A., Kitabayashi, N., Moss, B.J., Macdonald, T.Y., Cao, X., Barrette, T., Tewari, A.K., Chee, M.S., Chinnaiyan, A.M., Rickman, D.S., Demichelis, F., Gerstein, M.B., Rubin, M.A., Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 21 (2011), 56–67.
149. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordonez, G.R., Villamor, N., Escaramis, G., Jares, P., Bea, S., Gonzalez-Diaz, M., Bassaganyas, L., Baumann, T., Juan, M., Lopez-Guerra, M., Colomer, D., Tubio, J.M., Lopez, C., Navarro, A., Tornador, C., Aymerich, M., Rozman, M., Hernandez, J.M., Puente, D.A., Freije, J.M., Velasco, G., Gutierrez-Fernandez, A., Costa, D., Carrio, A., Guijarro, S., Enjuanes, A., Hernandez, L., Yague, J., Nicolas, P., Romeo-Casabona, C.M., Himmelbauer, H., Castillo, E., Dohm, J.C., De Sanjose, S., Piris, M.A., De Alava, E., San Miguel, J., Royo, R., Gelpi, J.L., Torrents, D., Orozco, M., Pisano, D.G., Valencia, A., Guigo, R., Bayes, M., Heath, S., Gut, M., Klatt, P., Marshall, J., Raine, K., Stebbings, L.A., Futreal, P.A., Stratton, M.R., Campbell, P.J., Gut, I., Lopez-Guillermo, A., Estivill, X., Montserrat, E., Lopez-Otin, C., Campo, E., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475 (2011), 101–105.
150. Puente, X.S., Quesada, V., Osorio, F.G., Cabanillas, R., Cadinanos, J., Fraile, J.M., Ordonez, G.R., Puente, D.A., Gutierrez-Fernandez, A., Fanjul-Fernandez, M., Levy, N., Freije, J.M., Lopez-Otin, C., Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 88 (2011), 650–656.
151. Puente, X.S., Bea, S., Valdes-Mas, R., Villamor, N., Gutierrez-Abril, J., Martin-Subero, J.I., Munar, M., Rubio-Perez, C., Jares, P., Aymerich, M., Baumann, T., Beekman, R., Belver, L., Carrio, A., Castellano, G., Clot, G., Colado, E., Colomer, D., Costa, D., Delgado, J., Enjuanes, A., Estivill, X., Ferrando, A.A., Gelpi, J.L., Gonzalez, B., Gonzalez, S., Gonzalez, M., Gut, M., Hernandez-Rivas, J.M., Lopez-Guerra, M., Martin-Garcia, D., Navarro, A., Nicolas, P., Orozco, M., Payer, A.R., Pinyol, M., Pisano, D.G., Puente, D.A., Queiros, A.C., Quesada, V., Romeo-Casabona, C.M., Royo, C., Royo, R., Rozman, M., Russinol, N., Salaverria, I., Stamatopoulos, K., Stunnenberg, H.G., Tamborero, D., Terol, M.J., Valencia, A., Lopez-Bigas, N., Torrents, D., Gut, I., Lopez-Guillermo, A., Lopez-Otin, C., Campo, E., Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526 (2015), 519–524.
152. Ragnauth, C.D., Warren, D.T., Liu, Y., Mcnair, R., Tajsic, T., Figg, N., Shroff, R., Skepper, J., Shanahan, C.M., Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121 (2010), 2200–2210.
153. Ramirez, C.L., Cadinanos, J., Varela, I., Freije, J.M., Lopez-Otin, C., Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell. Mol. Life Sci. 64 (2007), 155–170.
154. Rando, T.A., Chang, H.Y., Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148 (2012), 46–57.
155. Razani, B., Reichardt, A.D., Cheng, G., Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives. Immunol. Rev. 244 (2011), 44–54.
156. Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O.L., Medema, R.H., Hummerich, H., Jat, P.S., Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30 (2011), 2356–2366.
157. Rudolph, D., Yeh, W.C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., Mak, T.W., Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14 (2000), 854–862.
158. Rumore, M.M., Kim, K.S., Potential role of salicylates in type 2 diabetes. Ann. Pharmacother. 44 (2010), 1207–1221.
159. Saccani, S., Marazzi, I., Beg, A.A., Natoli, G., Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 200 (2004), 107–113.
160. Salminen, A., Kaarniranta, K., NF-kappaB signaling in the aging process. J. Clin. Immunol. 29 (2009), 397–405.
161. Salminen, A., Kaarniranta, K., Regulation of the aging process by autophagy. Trends Mol. Med. 15 (2009), 217–224.
162. Salminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., Suuronen, T., Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res. Rev. 7 (2008), 83–105.
163. Salminen, A., Kauppinen, A., Kaarniranta, K., Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell. Signal. 24 (2012), 835–845.
164. Scaffidi, P., Misteli, T., Lamin A-dependent nuclear defects in human aging. Science 312 (2006), 1059–1063.
165. Schlottmann, S., Buback, F., Stahl, B., Meierhenrich, R., Walter, P., Georgieff, M., Senftleben, U., Prolonged classical NF-kappaB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation. Mediators Inflamm., 2008, 2008, 725854.
166. Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israel, A., Rajewsky, K., Pasparakis, M., NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5 (2000), 981–992.
167. Schmitt, A.M., Crawley, C.D., Kang, S., Raleigh, D.R., Yu, X., Wahlstrom, J.S., Voce, D.J., Darga, T.E., Weichselbaum, R.R., Yamini, B., p50 (NF-kappaB1) is an effector protein in the cytotoxic response to DNA methylation damage. Mol. Cell. 44 (2011), 785–796.
168. Schreiber, V., Dantzer, F., Ame, J.C., De Murcia, G., Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell. Biol. 7 (2006), 517–528.
169. Sen, R., Baltimore, D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986), 705–716.
170. Sha, W.C., Liou, H.C., Tuomanen, E.I., Baltimore, D., Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80 (1995), 321–330.
171. Siggers, T., Chang, A.B., Teixeira, A., Wong, D., Williams, K.J., Ahmed, B., Ragoussis, J., Udalova, I.A., Smale, S.T., Bulyk, M.L., Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nat. Immunol. 13 (2012), 95–102.
172. Smith, L.K., He, Y., Park, J.S., Bieri, G., Snethlage, C.E., Lin, K., Gontier, G., Wabl, R., Plambeck, K.E., Udeochu, J., Wheatley, E.G., Bouchard, J., Eggel, A., Narasimha, R., Grant, J.L., Luo, J., Wyss-Coray, T., Villeda, S.A., beta2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 21 (2015), 932–937.
173. Soria-Valles, C., Osorio, F.G., Gutierrez-Fernandez, A., De Los Angeles, A., Bueno, C., Menendez, P., Martin-Subero, J.I., Daley, G.Q., Freije, J.M., Lopez-Otin, C., NF-kappaB activation impairs somatic cell reprogramming in ageing. Nat. Cell. Biol. 17 (2015), 1004–1013.
174. Soria-Valles, C., Osorio, F.G., Lopez-Otin, C., Reprogramming aging through DOT1L inhibition. Cell Cycle 14 (2015), 3345–3346.
175. Sousa-Victor, P., Gutarra, S., Garcia-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardi, M., Ballestar, E., Gonzalez, S., Serrano, A.L., Perdiguero, E., Munoz-Canoves, P., Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506 (2014), 316–321.
176. Sousa-Victor, P., Garcia-Prat, L., Serrano, A.L., Perdiguero, E., Munoz-Canoves, P., Muscle stem cell aging: regulation and rejuvenation. Trends Endocrinol. Metab. 26 (2015), 287–296.
177. Spencer, N.F., Poynter, M.E., Im, S.Y., Daynes, R.A., Constitutive activation of NF-kappa B in an animal model of aging. Int. Immunol. 9 (1997), 1581–1588.
178. Steinman, L., Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118 (2008), 3557–3563.
179. Strong, R., Miller, R.A., Astle, C.M., Floyd, R.A., Flurkey, K., Hensley, K.L., Javors, M.A., Leeuwenburgh, C., Nelson, J.F., Ongini, E., Nadon, N.L., Warner, H.R., Harrison, D.E., Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 7 (2008), 641–650.
180. Studer, L., Vera, E., Cornacchia, D., Programming and reprogramming cellular age in the era of induced pluripotency. Cell Stem Cell 16 (2015), 591–600.
181. Suda, T., Ueno, Y., Fujii, K., Shinki, T., Vitamin D and bone. J. Cell. Biochem. 88 (2003), 259–266.
182. Sun, S.C., Non-canonical NF-kappaB signaling pathway. Cell Res. 21 (2011), 71–85.
183. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., Akira, S., Limb and skin abnormalities in mice lacking IKKalpha. Science 284 (1999), 313–316.
184. Tanaka, M., Fuentes, M.E., Yamaguchi, K., Durnin, M.H., Dalrymple, S.A., Hardy, K.L., Goeddel, D.V., Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10 (1999), 421–429.
185. Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., Verma, I., p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1 (2002), 493–503.
186. Tilstra, J.S., Robinson, A.R., Wang, J., Gregg, S.Q., Clauson, C.L., Reay, D.P., Nasto, L.A., St Croix, C.M., Usas, A., Vo, N., Huard, J., Clemens, P.R., Stolz, D.B., Guttridge, D.C., Watkins, S.C., Garinis, G.A., Wang, Y., Niedernhofer, L.J., Robbins, P.D., NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122 (2012), 2601–2612.
187. Van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
188. Varela, I., Cadinanos, J., Pendas, A.M., Gutierrez-Fernandez, A., Folgueras, A.R., Sanchez, L.M., Zhou, Z., Rodriguez, F.J., Stewart, C.L., Vega, J.A., Tryggvason, K., Freije, J.M., Lopez-Otin, C., Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437 (2005), 564–568.
189. Varela, I., Pereira, S., Ugalde, A.P., Navarro, C.L., Suarez, M.F., Cau, P., Cadinanos, J., Osorio, F.G., Foray, N., Cobo, J., De Carlos, F., Levy, N., Freije, J.M., Lopez-Otin, C., Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14 (2008), 767–772.
190. Venable, M.E., Lee, J.Y., Smyth, M.J., Bielawska, A., Obeid, L.M., Role of ceramide in cellular senescence. J. Biol. Chem. 270 (1995), 30701–30708.
191. Verstrepen, L., Beyaert, R., Receptor proximal kinases in NF-kappaB signaling as potential therapeutic targets in cancer and inflammation. Biochem. Pharmacol. 92 (2014), 519–529.
192. Villeda, S.A., Luo, J., Mosher, K.I., Zou, B., Britschgi, M., Bieri, G., Stan, T.M., Fainberg, N., Ding, Z., Eggel, A., Lucin, K.M., Czirr, E., Park, J.S., Couillard-Despres, S., Aigner, L., Li, G., Peskind, E.R., Kaye, J.A., Quinn, J.F., Galasko, D.R., Xie, X.S., Rando, T.A., Wyss-Coray, T., The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477 (2011), 90–94.
193. Von Zglinicki, T., Martin-Ruiz, C.M., Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. 5 (2005), 197–203.
194. Wang, E., Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55 (1995), 2284–2292.
195. Wernstedt Asterholm, I., Tao, C., Morley, T.S., Wang, Q.A., Delgado-Lopez, F., Wang, Z.V., Scherer, P.E., Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20 (2014), 103–118.
196. Wu, Y., Deng, J., Rychahou, P.G., Qiu, S., Evers, B.M., Zhou, B.P., Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell. 15 (2009), 416–428.
197. Wyss-Coray, T., Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 12 (2006), 1005–1015.
198. Xia, Y., Shen, S., Verma, I.M., NF-kappaB, an active player in human cancers. Cancer Immunol. Res. 2 (2014), 823–830.
199. Yan, J., Zhang, H., Yin, Y., Li, J., Tang, Y., Purkayastha, S., Li, L., Cai, D., Obesity- and aging-induced excess of central transforming growth factor-beta potentiates diabetic development via an RNA stress response. Nat. Med. 20 (2014), 1001–1008.
200. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., Mayo, M.W., Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004), 2369–2380.
201. Yu, B., Chang, J., Liu, Y., Li, J., Kevork, K., Al-Hezaimi, K., Graves, D.T., Park, N.H., Wang, C.Y., Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-kappaB. Nat. Med. 20 (2014), 1009–1017.
202. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., Shoelson, S.E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001), 1673–1677.
203. Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., Cai, D., Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 497 (2013), 211–216.
204. Zhao, J., Li, X., Mcgowan, S., Niedernhofer, L.J., Robbins, P.D., NF-kappaB activation with aging: characterization and therapeutic inhibition. Methods Mol. Biol. 1280 (2015), 543–557.
205. Zou, Z., Huang, B., Wu, X., Zhang, H., Qi, J., Bradner, J., Nair, S., Chen, L.F., Brd4 maintains constitutively active NF-kappaB in cancer cells by binding to acetylated RelA. Oncogene 33 (2014), 2395–2404.